For the Inventor, By the Inventor

Enter assignee name

Guilford, CT, United States of America

Ai Therapeutics, Inc.

USPTO Granted Patents = 14

CIPO Patents = 3

EPO Patents = 9

Trademarks = 1

Forward Citations = 35

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Henri Lichenstein (14 out of 31 patents)

Jonathan Marc Rothberg (14 out of 402 patents)

Sean Landrette (8 out of 13 patents)

4. Lawrence S Melvin, Jr (6 out of 8 patents)

5. Thomas A Armer (6 out of 41 patents)

6. Neil Beeharry (5 out of 8 patents)

7. Paul Beckett (5 out of 9 patents)

8. Chris Conrad (5 out of 7 patents)

9. Tian Xu (5 out of 27 patents)

10. Sophia Gayle (4 out of 6 patents)

11. Peter R Young (2 out of 29 patents)

12. Matt Dyer (1 out of 4 patents)

13. Marylens Hernandez (2 patents)

14. Tian Xu (1 patent)

15. Lawrence S Melvin (0 patent)

14 patents: Sort by Forward Citations

1. 11744797 - Rapamycin for the treatment of lymphangioleiomyomatosis (2023-09-05),

2. 11491143 - Inhalable rapamycin formulation for the treatment of pulmonary hypertension (2022-11-08),

3. 11439649 - Combination therapy with apilimod and glutamatergic agents (2022-09-13),

4. 11266654 - Apilimod compositions and methods for using same (2022-03-08),

5. 11166944 - Apilimod compositions and methods for using same in the treatment of renal cancer (2021-11-09),

6. 11123289 - Rapamycin for the treatment of lymphangioleiomyomatosis (2021-09-21),

7. 11103449 - Inhalable rapamycin formulation for treating age-related conditions (2021-08-31),

8. 10765682 - Apilimod for use in the treatment of melanoma (2020-09-08),

9. 10751345 - Combination therapy with apilimod and glutamatergic agents (2020-08-25),

10. 10729694 - Anti-viral compositions containing PIKfyve inhibitors and use thereof (2020-08-04),

11. 10702534 - Compositions and methods relating to the radioprotective effects of apilimod (2020-07-07),

12. 10350213 - Methods for treating cancer using apilimod (2019-07-16),

13. 10307371 - Rapamycin for the treatment of lymphangioleiomyomatosis (2019-06-04),

14. 10307370 - Rapamycin for the treatment of lymphangioleiomyomatosis (2019-06-04),

AI Therapeutics, Inc. is a biotechnology company specialized in using artificial intelligence (AI) to develop novel therapies. By harnessing the power of AI algorithms, we aim to identify and repurpose existing drugs for new therapeutic applications, enabling faster and more cost-effective drug discovery. Our innovative approach has the potential to transform the healthcare industry by rapidly bringing safe, effective, and affordable treatments to patients in need. Visit our website to learn more about our groundbreaking research and the latest advancements in AI-driven drug development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#10 in Guilford, CT

#466 in Connecticut

#21,640 in US

#40,937 in the World

Guilford, CT, United States of America

Ai Therapeutics, Inc.

Forward Citations = 35

12 inventors:

Henri Lichenstein (14 out of 31 patents)

Jonathan Marc Rothberg (14 out of 402 patents)

Sean Landrette (8 out of 13 patents)

4. Lawrence S Melvin, Jr (6 out of 8 patents)

5. Thomas A Armer (6 out of 41 patents)

Please report any incorrect information to support@idiyas.com

Loading…